Slide

Oct. 2015 | IPF Partners announces Final Close of its Healthcare Growth Debt Fund

October 12, 2015.

IPF Partners, an AIFM debt fund manager set-up by a group of healthcare and debt investment executives led by Georges Ralli, former CEO of Lazard Investment Bank in Europe, has increased commitments into its first fund to over €105m. In this final closing, the fund secured commitments from new institutional investors.

Since fund launch in October 2013, IPF Partners has completed 5 investments, committing c. €50m into small and mid-sized commercial-stage European healthcare companies active in the medical technology, medical equipment and diagnostic fields. The fund targets returns of 15-20% from bespoke financings of €5-20m.

In addition to Georges Ralli the founding partners of IPF include Edouard Guillet, formerly a senior executive at Gilead Sciences, Medtronic and the Boston Consulting Group, Bernice Welles, formerly a venture partner at MPM Capital, a leading life sciences venture capital fund, and Vice President of Product Development at Genentech and Raeto Guler, formerly a debt financier with Macquarie’s Special Situations Lending Team and Barclays Capital.

Georges Ralli commented: “We are delighted to have achieved this final closing for our first fund with support from leading institutional investors. We recently completed our fifth investment and are excited about the growing demand for our type of financing from both private and public companies.”